FNY Investment Advisers’s Apellis Pharmaceuticals APLS Stock Holding History

FNY Investment Advisers’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-63,092	Closed	-$2.54M	–	858
2026 Q1	$2.54M	Buy	+63,092	New	+$1.36M	1.11%	20
2021 Q3	–	Sell	-1,031	Closed	-$65K	–	692
2021 Q2	$65K	Buy	+1,031	New	+$53.2K	0.03%	360

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's APLS Position: Q2 2026 in Review

FNY Investment Advisers sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 63,092 shares — an estimated $2.54M sold.

FNY Investment Advisers first reported a position in APLS in Q2 2021 and held it in 2 quarters. The position peaked at $2.54M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

FNY Investment Advisers reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 63,092 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.54M.
FNY Investment Advisers first reported a position in Apellis Pharmaceuticals in Q2 2021 and held it in 2 quarters.
FNY Investment Advisers's Apellis Pharmaceuticals position peaked at $2.54M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.